Public Company News

Lunit and Summit Therapeutics Announce Agreement to Apply AI-powered SCOPE IO Platform for Tumor Microenvironment Analysis in Immuno-Oncology Development

Research Will Use Lunit's AI-powered Pathology Platform to Analyze H&E Whole-Slide Images and Generate Scalable Insights into Tumor Microenvironment Biology SEOUL, South Korea, Oct. 24, 2026 /PRNewswire/ -- Lunit Inc. (KRX: 328130) and Summit Therapeutics Inc. (NASDAQ: SMMT) today announced a re...

2026-10-24 09:26 816

REJURAN® COSMETICS Expands U.S. Retail Presence Through Costco's First-Ever Beauty Table Program

The premium Korean skincare brand introduces a Costco member set featuring its c-PDRN®-powered Turnover Ampoule SEOUL, South Korea, Oct. 23, 2026 /PRNewswire/ -- REJURAN® COSMETICS is expanding its U.S. retail presence through Costco's new Beauty Table program, bringing its c-PDRN® skincare to m...

2026-10-24 00:07 1833

OUE REIT Strengthens Presence in Sydney's CBD with Proposed Acquisition of Additional c.50% Interest in 180 George Street for an Agreed Property Price of A$864.0 million

* Raises OUE REIT's interest in 180 George Street from 19.9% to 69.9% upon completion * Expected to deliver pro forma DPU accretion of 3.2%[1] * Establishes a majority interest in a premium freehold asset in Sydney's core CBD * Funded through debt and partial net proceeds from the divestme...

2026-10-23 22:22 3745

GoDaddy Brings 'Ink Your Link' Campaign to NYC: NYSE Content Update

NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, Oct. 23, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begin...

2026-10-23 21:19 3101

Infosys:Differentiated AI strategy and a sharp focus on value unlock propels 29% sequential growth in AI revenues

* Robust Q2 large deal TCV at $5.2 billion with 62% net new; lays solid foundation for future growth * FY 27 revenue guidance revised to 1%-2% and margin guidance retained at 20%-22% BENGALURU, India, Oct. 23, 2026 /PRNewswire/ -- Infosys (NSE: INFY) (BSE: INFY) (NY...

2026-10-23 21:07 2712

AMTD IDEA's Total Assets Exceeded US$2.6 Billion as of 2026 Half Year and Sets Forth Clear Growth Path in Global Hospitality

* Revenue from contracts with customers grew by 32.1% to US$32.0 million * Hospitality arm's revenue surged by 59.8% * Total Assets amounted to US$2.6 billion (US$4.5/share) * Net Assets amounted to US$1.9 billion (US$3.3/share) PARIS and NEW YORK and SINGAPORE, Oct. 23, 2026 /PRNewswire...

2026-10-23 20:24 2831

Zai Lab's Zocilurtatug Pelitecan (Zoci, Formerly ZL-1310) Demonstrates High Response Rates, Encouraging Durability and Well-Tolerated Safety Profile in First-Line Extensive-Stage Small Cell Lung Cancer

-  At the recommended Phase 3 dose (RP3D) of 1.6 mg/kg, zoci plus atezolizumab achieved a confirmed objective response rate of 81.8% (27/33) and an estimated 6-month progression-free survival rate of 81.9% (n=33) in 1L ES-SCLC -  Among patients with at least six-months follow-up (n=15) treated at...

2026-10-23 20:04 1904

Coreline Soft Receives U.S. FDA 510(k) Clearance for AVIEW Aorta Metrics, Expanding Its Chest CT AI Portfolio in the U.S.

* Secures its 13th FDA 510(k) clearance, expanding its U.S. portfolio from lung nodule detection and coronary artery calcium (CAC) analysis to quantitative aortic assessment * Enables automated aortic segmentation and diameter measurements across anatomical regions, broadening the quantitativ...

2026-10-23 20:00 2317

2026 ESMO LBA | Innovent Announces International Phase 3 Study of Arcotatug Tavatecan (CLDN18.2-ADC) in Gastric Cancer Met Dual Primary Endpoints of PFS and OS

* Registrational Phase 3 G-HOPE-001 Study Met Both Primary Endpoints, Demonstrating Statistically Significant and Clinically Meaningful Overall Survival and Progression-Free Survival Benefits in Previously Treated, CLDN18.2-positive Gastric Cancer * Arcotatug Tavatecan Demonstrated a Favorabl...

2026-10-23 20:00 1987

Alebund Pharmaceuticals Announces Poster Presentation by Partner R1 Therapeutics of Global Phase IIb Multi-Regional Clinical Trial Design for AP306 at ASN Kidney Week 2026

SHANGHAI, Oct. 23, 2026 /PRNewswire/ -- Alebund Pharmaceuticals (Jiangsu) Limited ("Alebund" or the "Company"; HKEX: 09637), a renal-focused biopharmaceutical company, today announced that its partner, R1 Therapeutics, Inc. ("R1"), presented a trial-in-progress poster outlining the design of the ...

2026-10-23 19:00 2235

Financial Report July - September 2026

STOCKHOLM, Oct. 23, 2026 /PRNewswire/ -- Q3 2026: Solid performance in a tough environment Financial highlights Q3 2026 $2,693 million net sales, a decrease of 0.5% 1.1% organic sales decrease* 9.4% operating margin, 9.7% adj. operating margin* $2.13 diluted EPS, a 6.8% decrease Full year 2026 g...

2026-10-23 18:47 1648

Angel Yeast Marks 40th Anniversary, Setting Its Sights on Becoming a Global Biotech Powerhouse

YICHANG, China, Oct. 23, 2026 /PRNewswire/ -- Angel Yeast (SSE: 600298), one of the world's leading yeast manufacturers, has hosted the 2026 International Synthetic Biology Symposium and the Angel Group High-Quality Development Conference in Yichang, its headquarters ...

2026-10-23 18:10 1445

JinkoSolar Completes Name Change to Jinko Holdings Limited

ADSs continue to trade under "JKS"; Company to Enhance Transparency on Strategic Investment Portfolio SHANGRAO, China, Oct. 23, 2026 /PRNewswire/ -- Jinko Holdings Limited ("Jinko Holdings" or the "Company") (NYSE: JKS), formerly JinkoSolar Holding Co., Ltd., today announced that its new company...

2026-10-23 18:03 1276

Amber International Holding Limited Announces Results of the Annual General Meeting on October 23, 2026

SINGAPORE, Oct. 23, 2026 /PRNewswire/ -- Amber International Holding Limited ("Amber International" or the "Company") (NASDAQ: AMBR) today announced the results of the Company's annual general meeting of shareholders (the "AGM") held in Singapore today. At the AGM, shareholders approved, ratifie...

2026-10-23 17:45 1868

Zoomlion Tower Cranes Combine Heavy Lifting and Precision Control for Construction at Height

CHANGSHA, China, Oct. 23, 2026 /PRNewswire/ -- Zoomlion Heavy Industry Science & Technology Co., Ltd. ("Zoomlion") supported the Sept. 29 topping out of the 283-meter Shangri-La-side main tower of China's Lugu Lake Grand Bridge. Two R4300-200 tower cranes served the bridge's main towers. Alongside...

2026-10-23 17:36 1385

DBS recognised as Safest Bank in Asia for the 18th consecutive year

Global Finance rankings recognise institutions that have demonstrated financial strength and long-term resilience SINGAPORE, Oct. 23, 2026 /PRNewswire/ -- DBS announced today that it has once again been named "Safest Bank in Asia" by Global Finance, marking the 18th consecutive year that the ban...

2026-10-23 15:30 1400

Volvo Cars Q3 2026: taking decisive action to navigate a very tough environment

GOTHENBURG, Sweden, Oct. 23, 2026 /PRNewswire/ -- Volvo Cars today reports an operating income, excluding joint ventures & associates and items affecting comparability, of SEK -3.7 billion and a corresponding EBIT margin of -5.6 per cent for the third quarter of 2026. The result reflects a furthe...

2026-10-23 14:20 1401

Electrolux Group Interim report Q3 2026

STOCKHOLM, Oct. 23, 2026 /PRNewswire/ --  Highlights of the third quarter of 2026 * Net sales increased to SEK 33,919m (32,318) with organic sales growth of 3.5% (4.6). All regions contributed to the growth, driven mainly by increased sales volumes in Europe, Middle East & Africa, Asia Pacific...

2026-10-23 14:02 1514

Ping An Good Doctor's Nine-Month Net Profit Rises 35%; Company Accelerates Efforts to Broaden AI Applications in Healthcare

HONG KONG and SHANGHAI, Oct. 23, 2026 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited ("Ping An Good Doctor" or the "Company"; Stock Code: 1833.HK) today announced its results for the nine months ended 30 September 2026. During the period, the Company recorded total revenue of R...

2026-10-23 12:18 2149

LianLian Global and PayPal Power Cross-Border Payouts for Social Commerce, Marketplace, and eCommerce Customers

Social commerce, marketplaces and eCommerce players served by LianLian Global can now pay creators, influencers, developers, and independent contractors directly to their PayPal and Venmo wallets. NEW YORK, Oct. 22, 2026 /PRNewswire/ -- LianLian Global  today anno...

2026-10-23 10:27 6523
12345 ... 1655